<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Latest Medical Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/medicine-technology-1/</link>
<description>Latest Medical Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2007. Bio-Medicine All Rights Reserved.</copyright>
<item>
<title><![CDATA[First Paralyzed Formula Race Car Driver's &quot;Road to Indy&quot; Sponsored By Coloplast]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/First-Paralyzed-Formula-Race-Car-Drivers--26quot-3BRoad-to-Indy-26quot-3B-Sponsored-By-Coloplast-25538-1/</link>
<pubDate>Tue, 15 May 2012 01:38:43 MST</pubDate>
<description><![CDATA[MINNEAPOLIS, May 15, 2012 /-&#160;Coloplast North America, a provider of products and services for people with intimate medical needs, has announced a corporate sponsorship of Michael Johnson, formula racing's first paralyzed driver.   Johnson, 19, is competing this year in The Cooper Tires USF2000 Championship Powered by Mazda, the first step on the Road to Indy, an open-wheeled de... ]]></description>
</item>
<item>
<title><![CDATA[Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Pressure-BioSciences--Inc--to-Discuss-First-Quarter-2012-Financial-Results-And-Provide-Business-Update-25537-1/</link>
<pubDate>Tue, 15 May 2012 01:38:16 MST</pubDate>
<description><![CDATA[SOUTH EASTON, Mass., May 15, 2012 /- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2012 financial results and to provide a business update.&#160; Anyone interested may listen to the teleconference either by telephone or through a live web-cast.&#160; The teleconference and w... ]]></description>
</item>
<item>
<title><![CDATA[Fluke Biomedical launches speedy new ProSim™ SPOT Light SpO2 Functional Tester]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Fluke-Biomedical-launches-speedy-new-ProSim-u2122-SPOT-Light-SpO2-Functional-Tester-25536-1/</link>
<pubDate>Tue, 15 May 2012 01:37:55 MST</pubDate>
<description><![CDATA[EVERETT, Wash., May 15, 2012 /-&#160;Fluke Biomedical announced today the newest addition to their ProSim family of patient monitor quality-assurance testing and troubleshooting tools, the  SPOT Light SpO2 Functional Tester . Citing a record 15-second preventive maintenance (PM) test for SpO2 patient monitor functionality, the new ProSim SPOT Light is the fastest SpO2 functional tes... ]]></description>
</item>
<item>
<title><![CDATA[PLC Systems Reports First Quarter 2012 Results]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/PLC-Systems-Reports-First-Quarter-2012-Results-25535-1/</link>
<pubDate>Tue, 15 May 2012 01:37:27 MST</pubDate>
<description><![CDATA[MILFORD, Mass., May 15, 2012 /-&#160;PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today reported financial results for the three-month period ended March 31, 2012. These results only include the company's RenalGuard&#174; operations, since PLC completed the sale of its transmyocardial revascularization (TMR) business to Novadaq Corp.... ]]></description>
</item>
<item>
<title><![CDATA[PGI Reports First Quarter 2012 Results]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/PGI-Reports-First-Quarter-2012-Results-25534-1/</link>
<pubDate>Tue, 15 May 2012 01:37:00 MST</pubDate>
<description><![CDATA[CHARLOTTE, N.C., May 15, 2012 /-&#160;Polymer Group, Inc. (PGI) (the "Company") reported results of operations for the first quarter ended March 31, 2012.   As previously announced, Polymer Group, Inc. finalized the merger with the Blackstone Group, along with co-investors, and certain members of the Company's management (the "Merger") on January 28, 2011 and became a privately held... ]]></description>
</item>
<item>
<title><![CDATA[Medical Marijuana, Inc. Announces First Quarter 2012 Results]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Medical-Marijuana--Inc--Announces-First-Quarter-2012-Results-25533-1/</link>
<pubDate>Tue, 15 May 2012 01:36:03 MST</pubDate>
<description><![CDATA[SAN DIEGO, May 15, 2012 /-  Medical Marijuana, Inc . (OTC: MJNA), one of the medical marijuana (MMJ) industry's premier cannabis and hemp industry innovators, today announced its first quarter earnings.&#160; The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012.&#160; This represents a gross revenue incr... ]]></description>
</item>
<item>
<title><![CDATA[BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/BiO2-Medical-Granted-CE-Mark-for-the-Angel-u2122-Catheter--the-First-IVC-Filter-with-a-Prophylactic-Use-Indication-25532-1/</link>
<pubDate>Tue, 15 May 2012 01:34:37 MST</pubDate>
<description><![CDATA[SAN ANTONIO, May 15, 2012 /- BiO2 Medical, Inc. a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&amp;D and manufacturing operations in Golden, Colorado, announced today that it has received CE Mark approval for the Angel&#8482; Catheter, a Nitinol Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for... ]]></description>
</item>
<item>
<title><![CDATA[Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Arena-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock-25531-1/</link>
<pubDate>Tue, 15 May 2012 01:33:47 MST</pubDate>
<description><![CDATA[SAN DIEGO, May 15, 2012 /- Arena Pharmaceuticals, Inc. (NASDAQ:   ARNA ) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.   Jefferies &amp; Company, I... ]]></description>
</item>
<item>
<title><![CDATA[Vermillion Announces CEO Succession Plan]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Vermillion-Announces-CEO-Succession-Plan-25530-1/</link>
<pubDate>Tue, 15 May 2012 01:33:12 MST</pubDate>
<description><![CDATA[AUSTIN, Texas, May 15, 2012 /-&#160;The board of directors of Vermillion, Inc. (NASDAQ:   VRML ), a leading molecular diagnostics company, has begun the process of identifying a successor to Gail S. Page, president and CEO. The board has formed a search committee, with the goal of completing the search by September 2012.   James S. Burns, Vermillion's chairman of the board, commente... ]]></description>
</item>
<item>
<title><![CDATA[One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus  PROMUS Element™ Platinum Chromium Stent]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/One-Year-EVOLVE-Trial-Clinical-Results-Confirm-Comparable-Safety-And-Effectiveness-Data-Of-The-Boston-Scientific-SYNERGY-u2122-Stent-Versus--PROMUS-El-25529-1/</link>
<pubDate>Tue, 15 May 2012 11:22:54 MST</pubDate>
<description><![CDATA[NATICK, Mass., May 15, 2012 /-&#160;Boston Scientific Corporation (NYSE:   BSX ) announces that the SYNERGY&#8482; Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent System demonstrated non-inferior results in treating  de novo  coronary artery lesions at one year compared to the PROMUS Element&#8482; Everolimus-Eluting Platinum Chromium Stent System in... ]]></description>
</item>
<item>
<title><![CDATA[Millennium Surgical Corp. Announces Sales Figures, Growth]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Millennium-Surgical-Corp--Announces-Sales-Figures--Growth-25528-1/</link>
<pubDate>Tue, 15 May 2012 11:22:27 MST</pubDate>
<description><![CDATA[NARBERTH, Pa., May 15, 2012 /- Millennium Surgical Corp. continues to achieve strong revenue and expand its client base. Sales activity increased in the third quarter of 2011 and continues to accelerate through 2012.&#160;Sales figures and the number of new clients for the first four months of 2012 were up 30% over the same period in FY2011. To accommodate additional clients and the... ]]></description>
</item>
<item>
<title><![CDATA[InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/InfuSystem-Holdings--Inc--To-Announce-First-Quarter-2012-Financial-Results-On-May-21--2012-25527-1/</link>
<pubDate>Tue, 15 May 2012 11:22:06 MST</pubDate>
<description><![CDATA[MADISON HEIGHTS, Mich., May 15, 2012 /-&#160;InfuSystem Holdings, Inc. (NYSE MKT: &#160;INFU), the leading national provider of infusion pumps and related services for the healthcare industry, today announced that it will release results for the first quarter 2012 on Monday, May 21, 2012 following the market close.&#160;    The Company will host a live conference call on Tuesday, Ma... ]]></description>
</item>
<item>
<title><![CDATA[Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Attendees-Save-up-to--24350-on-CHI-Conferences-This-Summer-by-Registering-Through-Global-Information-25526-1/</link>
<pubDate>Tue, 15 May 2012 11:21:26 MST</pubDate>
<description><![CDATA[FARMINGTON, Conn., May 15, 2012  /PRNewswire-iReach/  -- Global Information Inc. announces Early Bird discounted registration for three important&#160;Cambridge Healthtech Institute conferences:    IMVACS &#8211; The Immunotherapeutics and Vaccine Summit     August 13 &#8211; 15, Cambridge, MA  - The IMVACS 2012 Summit will brings together three excellent conferences under one heading: the Seven... ]]></description>
</item>
<item>
<title><![CDATA[Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Contract-Research-Organizations-Set-to-Experience-Rapid-Growth-as-Development-Costs-for-New-Drugs-Continue-to-Rise-25525-1/</link>
<pubDate>Tue, 15 May 2012 11:21:07 MST</pubDate>
<description><![CDATA[FARMINGTON, Conn., May 15, 2012  /PRNewswire-iReach/  -- Global Information Inc. is pleased to announce two significant new reports on Drug Development:    Contract Research Organizations Market to 2018  The Contract Research Organizations industry grew at the rate of 12% from 2009 to 2010 according to GBI Research's new market research report,  Contract Research Organizations Market to 2018 : P... ]]></description>
</item>
<item>
<title><![CDATA[PLZ Aeroscience Acquires Assured Packaging]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/PLZ-Aeroscience-Acquires-Assured-Packaging-25524-1/</link>
<pubDate>Tue, 15 May 2012 11:06:05 MST</pubDate>
<description><![CDATA[ST. CLAIR, Mo., May 15, 2012 /-&#160;PLZ Aeroscience is pleased to announce the acquisition of Assured Packaging, located in Mississauga, Ontario, Canada.&#160; Assured is Canada's leading custom manufacturer of aerosols for the health and beauty aids, pharmaceutical, food and household market categories.&#160; With the Assured Packaging acquisition and the purchase of K-G Spray-Pak... ]]></description>
</item>
<item>
<title><![CDATA[EnerJel™ Adds 200 Independent Pharmacies To Distribution Base]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/EnerJel-u2122-Adds-200-Independent-Pharmacies-To-Distribution-Base-25523-1/</link>
<pubDate>Tue, 15 May 2012 10:48:02 MST</pubDate>
<description><![CDATA[MIAMI LAKES, Fla., May 15, 2012 /-&#160;Fuse Science Inc. (OTCQB: DROP), ( www.fusescience.com ) announced today that it has added another 200 independent pharmacies in South Florida through a distribution partnership with GAT Trading Inc. out of Doral, Florida. Distribution build out has begun, led by GAT Trading President, Gustavo Tobon, in response to interest by pharmacists with... ]]></description>
</item>
<item>
<title><![CDATA[GeoVax Labs Reports 2012 First Quarter Financial Results]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/GeoVax-Labs-Reports-2012-First-Quarter-Financial-Results-25522-1/</link>
<pubDate>Tue, 15 May 2012 09:28:50 MST</pubDate>
<description><![CDATA[ATLANTA, May 15, 2012 /-&#160;GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced its financial results for the three months ended March 31, 2012 and provided a business update.   "We are delighted with recent developments that have strengthened and advanced our HIV/AIDS vaccine program," said Chairm... ]]></description>
</item>
<item>
<title><![CDATA[AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/AXIOS-u2122-Stent-and-Delivery-System-Study-Demonstrates-Successful-Treatment-of-Pancreatic-Pseudocysts-and-Acute-Cholecystitis-25521-1/</link>
<pubDate>Tue, 15 May 2012 08:08:05 MST</pubDate>
<description><![CDATA[MOUNTAIN VIEW, Calif., May 15, 2012 /-&#160;Xlumena, Inc. announces the publication of a scientific paper describing the first human study of the AXIOS&#8482; Stent and Delivery System. The article, entitled "Clinical evaluation of a novel lumen-apposing metal stent for endosonography-guided pancreatic pseudocyst and gallbladder drainage" appeared in the April issue of  Gastrointest... ]]></description>
</item>
<item>
<title><![CDATA[Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Aethlon-Medical-to-Present-at-Todays-Security-Research-Associates-8th-Annual-Growth-Conference-25520-1/</link>
<pubDate>Tue, 15 May 2012 08:07:35 MST</pubDate>
<description><![CDATA[SAN DIEGO, May 15, 2012 /-&#160; Aethlon Medical, Inc.  (OTCBB: AEMD), announced that Chairman and CEO James A. Joyce will present at today's Security Research Associates (SRA) 8th Annual Growth Stock Conference. &#160;The Conference will be held at the Le Meriden Hotel in San Francisco.&#160; A live webcast of the presentation will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern... ]]></description>
</item>
<item>
<title><![CDATA[San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/San-Diego-Based-Neurosurgeon-Offers-Groundbreaking-Treatment-to-Restore-Function-for-People-Suffering-from-Mobility-Inhibiting-Paralysis-25519-1/</link>
<pubDate>Tue, 15 May 2012 08:06:42 MST</pubDate>
<description><![CDATA[SAN DIEGO, May 15, 2012 /-&#160;San Diego based neurosurgeon, Dr. Justin M. Brown, M.D., Director of the Neurosurgery Peripheral Nerve Program at UCSD School of Medicine, has implemented a procedure that helps patients recover movement in their hands and extremities after spinal cord and brain injuries, strokes, and other forms of paralysis.   Dr. Brown specializes in repairing nerv... ]]></description>
</item>
</channel>
</rss>
